Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma (vol 12, pg 1421, 2017)

被引：0
|
作者：
Kao, S. C.
Cheng, Y. Y.
Williams, M.
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：587 / 587
页数：1
相关论文
共 50 条
  • [41] Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis
    Riki Okita
    Nobutaka Kawamoto
    Masanori Okada
    Hidetoshi Inokawa
    Naoki Yamamoto
    Tomoyuki Murakami
    Eiji Ikeda
    Scientific Reports, 13
  • [42] Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma
    Inaguma, Shingo
    Lasota, Jerzy
    Wang, Zengfeng
    Czapiewski, Piotr
    Langfort, Renata
    Rys, Janusz
    Szpor, Joanna
    Waloszczyk, Piotr
    Okon, Krzysztof
    Biernat, Wojciech
    Ikeda, Hiroshi
    Schrump, David S.
    Hassan, Raffit
    Miettinen, Markku
    HUMAN PATHOLOGY, 2018, 71 : 1 - 7
  • [43] Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis
    Okita, Riki
    Kawamoto, Nobutaka
    Okada, Masanori
    Inokawa, Hidetoshi
    Yamamoto, Naoki
    Murakami, Tomoyuki
    Ikeda, Eiji
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression (vol 128, pg 805, 2018)
    Lin, Heng
    Wei, Shuang
    Hurt, Elaine M.
    Green, Michael D.
    Zhao, Lili
    Vatan, Linda
    Szeliga, Wojciech
    Herbst, Ronald
    Harms, Paul W.
    Fecher, Leslie A.
    Vats, Pankaj
    Chinnaiyan, Arul M.
    Lao, Christopher D.
    Lawrence, Theodore S.
    Wicha, Max
    Hamanishi, Junzo
    Mandai, Masaki
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1708 - 1708
  • [45] Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status
    Rrapaj, Eltjona
    Giacometti, Lorenzo
    Spina, Paolo
    Salvo, Michela
    Baselli, Guido Alessandro
    Veggiani, Claudia
    Rena, Ottavio
    Trisolini, Elena
    Boldorini, Renzo Luciano
    PATHOLOGY, 2020, 53 (04) : 462 - 469
  • [46] Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy"
    White, Michael G.
    Eng, Oliver S.
    BRITISH JOURNAL OF CANCER, 2021, 124 (06) : 1179 - 1180
  • [47] Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
    Mansour, Mohammed S. I.
    Seidal, Tomas
    Mager, Ulrich
    Dobra, Katalin
    Brunnstrom, Hans
    Dejmek, Annika
    CANCER CYTOPATHOLOGY, 2021, 129 (06) : 468 - 478
  • [48] Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
    Michael G. White
    Oliver S. Eng
    British Journal of Cancer, 2021, 124 : 1179 - 1180
  • [49] Analysis of expression of PTEN/PI3 K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
    Cedres, S.
    Ponce-Aix, S.
    Pardo-Aranda, N.
    Navarro-Mendivil, A.
    Martinez-Marti, A.
    Zugazagoitia, J.
    Sansano, I.
    Montoro, M. A.
    Enguita, A.
    Felip, E.
    LUNG CANCER, 2016, 96 : 1 - 6
  • [50] Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
    Hu, Lingrong
    Sun, Chengliang
    Yuan, Kai
    Yang, Peng
    DRUG DISCOVERY TODAY, 2024, 29 (11)
12345